MX2020006662A - Vacuna combinada intradermica contra mycoplasma y circovirus porcino. - Google Patents
Vacuna combinada intradermica contra mycoplasma y circovirus porcino.Info
- Publication number
- MX2020006662A MX2020006662A MX2020006662A MX2020006662A MX2020006662A MX 2020006662 A MX2020006662 A MX 2020006662A MX 2020006662 A MX2020006662 A MX 2020006662A MX 2020006662 A MX2020006662 A MX 2020006662A MX 2020006662 A MX2020006662 A MX 2020006662A
- Authority
- MX
- Mexico
- Prior art keywords
- porcine circovirus
- mycoplasma
- combination vaccine
- vaccine against
- antigens
- Prior art date
Links
- 241000202347 Porcine circovirus Species 0.000 title abstract 3
- 241000204031 Mycoplasma Species 0.000 title abstract 2
- 229940001442 combination vaccine Drugs 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 abstract 3
- 102000036639 antigens Human genes 0.000 abstract 3
- 108091007433 antigens Proteins 0.000 abstract 3
- 206010035664 Pneumonia Diseases 0.000 abstract 1
- 101100382437 Porcine circovirus 2 Cap gene Proteins 0.000 abstract 1
- 210000004207 dermis Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 244000144972 livestock Species 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/70—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in livestock or poultry
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17382893 | 2017-12-22 | ||
| PCT/EP2018/085844 WO2019121916A1 (en) | 2017-12-22 | 2018-12-19 | Intradermal combination vaccine against mycoplasma and porcine circovirus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020006662A true MX2020006662A (es) | 2020-08-31 |
Family
ID=61024548
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020006662A MX2020006662A (es) | 2017-12-22 | 2018-12-19 | Vacuna combinada intradermica contra mycoplasma y circovirus porcino. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11744883B2 (https=) |
| EP (1) | EP3727432A1 (https=) |
| JP (1) | JP7510874B2 (https=) |
| BR (1) | BR112020012483A2 (https=) |
| CA (1) | CA3085535A1 (https=) |
| MX (1) | MX2020006662A (https=) |
| WO (1) | WO2019121916A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11744883B2 (en) * | 2017-12-22 | 2023-09-05 | Hipra Scientific, S.L.U. | Intradermal combination vaccine against mycoplasma and porcine circovirus |
| US20220323567A1 (en) * | 2019-09-12 | 2022-10-13 | Intervet Inc. | Combination vaccine for intradermal administration |
| CN112294953A (zh) * | 2020-12-31 | 2021-02-02 | 北京科牧丰生物制药有限公司 | 一种pcv2型杆状病毒载体、猪肺炎支原体、副猪嗜血杆菌三联灭活疫苗及制备方法 |
| WO2024235714A1 (en) * | 2023-05-12 | 2024-11-21 | Intervet International B.V. | A vaccine against leptospira bacterium |
| WO2024235713A1 (en) * | 2023-05-12 | 2024-11-21 | Intervet International B.V. | A vaccine against erysipelothrix rhusiopathiae and porcine parvo virus |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5565205A (en) * | 1990-08-16 | 1996-10-15 | Solvay Animal Health, Inc. | Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof |
| EP1968630B1 (en) * | 2005-12-29 | 2018-01-24 | Boehringer Ingelheim Vetmedica, Inc. | Multivalent pcv2 immunogenic compositions |
| KR20100113582A (ko) * | 2008-01-23 | 2010-10-21 | 베링거잉겔하임베트메디카인코퍼레이티드 | Ｐｃｖ2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법 |
| UA114504C2 (uk) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
| US9120859B2 (en) * | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
| EP2684959A1 (en) | 2012-07-10 | 2014-01-15 | Laboratorios Hipra, S.A. | Vectors for transforming Mycoplasma hyopneumoniae, transformed M.hyopneumoniae strains, and use thereof |
| GB201220889D0 (en) | 2012-11-21 | 2013-01-02 | Kit Karlsrusher Inst Fuer Technologie Und Inst Fuer Toxikologie Und Genetik And Amcure Gmbh | CD44v6-derived peptides for treating metastasizing cancers |
| ES2882374T3 (es) * | 2013-05-08 | 2021-12-01 | Pharmgate Biologics Inc | Vacuna para PCV2 y micoplasma |
| EP3037119A1 (en) | 2014-12-23 | 2016-06-29 | Hipra Scientific, S.L.U. | Device for administering medicinal products |
| JP6839714B2 (ja) * | 2015-12-28 | 2021-03-10 | ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド | Ｍ Ｈｙｏ多重ワクチン及びその使用 |
| CN108697782A (zh) * | 2016-03-23 | 2018-10-23 | 英特维特国际股份有限公司 | 针对pcv2病毒和猪肺炎支原体感染的组合疫苗 |
| US11744883B2 (en) * | 2017-12-22 | 2023-09-05 | Hipra Scientific, S.L.U. | Intradermal combination vaccine against mycoplasma and porcine circovirus |
-
2018
- 2018-12-19 US US16/955,015 patent/US11744883B2/en active Active
- 2018-12-19 CA CA3085535A patent/CA3085535A1/en active Pending
- 2018-12-19 MX MX2020006662A patent/MX2020006662A/es unknown
- 2018-12-19 WO PCT/EP2018/085844 patent/WO2019121916A1/en not_active Ceased
- 2018-12-19 EP EP18833856.0A patent/EP3727432A1/en active Pending
- 2018-12-19 BR BR112020012483-4A patent/BR112020012483A2/pt unknown
- 2018-12-19 JP JP2020533815A patent/JP7510874B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019121916A1 (en) | 2019-06-27 |
| US11744883B2 (en) | 2023-09-05 |
| CA3085535A1 (en) | 2019-06-27 |
| EP3727432A1 (en) | 2020-10-28 |
| JP7510874B2 (ja) | 2024-07-04 |
| US20200376106A1 (en) | 2020-12-03 |
| JP2021506874A (ja) | 2021-02-22 |
| BR112020012483A2 (pt) | 2020-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020006662A (es) | Vacuna combinada intradermica contra mycoplasma y circovirus porcino. | |
| MX393855B (es) | Terapia de combinación que comprende un inhibidor de raf y trametinib | |
| WO2018136412A3 (en) | Subcutaneous her2 antibody formulations | |
| PH12021550479A1 (en) | Dengue vaccine unit dose and administration thereof | |
| UA124347C2 (uk) | Циклічна динуклеотидна сполука | |
| JOP20220092A1 (ar) | جسم مضاد لبيتا-النشواني لعلاج مرض الزهايمر | |
| MX392525B (es) | Composiciones inmunogenicas para su uso en vacunas neumococicas | |
| CA3030422C (en) | Stabilizing excipients for therapeutic protein formulations | |
| MX2021014948A (es) | Metodos de tratamiento de pacientes con una composicion inmunogenica que protege contra el seroripo 29 de s. pneumoniae. | |
| AR090885A1 (es) | Uso de laquinimod en alta dosis para el tratamiento de la esclerosis multiple | |
| BR112018069100A2 (pt) | uma vacina combinada contra a infecção por vírus pcv2 e mycoplasma hyopneumoniae | |
| ZA202107428B (en) | Porcine circovirus type 3 (pcv3) vaccines, and production and uses thereof | |
| UY32208A (es) | Uso de antigeno de mycoplasma bovis | |
| MX2020008454A (es) | Composicion inmunogenica que comprende antigenos estafilococicos. | |
| MX2022003090A (es) | Vacuna combinada para ser administrable intradermicamente. | |
| MX2015016750A (es) | Composicion inmunogenica para uso en terapia. | |
| BR112018014723A2 (pt) | fantasmas bacterianos para o tratamento de câncer | |
| MX2021005421A (es) | Macrólidos de 13 miembros con sustitución cíclica en c10 y usos de los mismos. | |
| BR112016012435A8 (pt) | vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2 | |
| MY191905A (en) | M hyo multivalent vaccine and uses thereof | |
| MX2021005423A (es) | Macrolidos de 13 miembros sustituidos con c10-alquileno y usos de los mismos. | |
| EP4335455A3 (en) | Vaccines containing swine pathogens for associated non-mixed use | |
| PH12020552130A1 (en) | Vaccination against porcine circoviruses | |
| RU2018137033A (ru) | Вакцина для внутрикожного применения против инфекции вируса pcv2 и prrs | |
| MX2022001937A (es) | Composicion inmunogenica. |